EGFR and non-small cell lung carcinoma: The aim of this SLR was to identify and comprehensively summarize the available evidence on the epidemiologic, clinical, humanistic, and economic burden of the EGFR Exon 20ins mutation in adult patients with advanced/metastatic NSCLC.